Abstract
Chronic Obstructive Pulmonary Disease (COPD) can be briefly described as air flow limitation and chronic dyspnea associated to an inflammatory response of the respiratory tract to noxious particles and gases. Its main feature is the obstruction of airflow and consequent chronic dyspnea. Despite recent advances, and the development of new therapeutic, medical and clinical approaches, a curative therapy is yet to be achieved. Therapies involving the use of tissue-specific or donor derived cells present a promising alternative in the treatment of degenerative diseases and injuries. Recent studies demonstrate that mesenchymal stem cells have the capacity to modulate immune responses in acute lung injury and pulmonary fibrosis in animal models, as well as in human patients. Due to these aspects, different groups raised the possibility that the stem cells from different sources, such as those found in bone marrow or adipose tissue, could act preventing the emphysematous lesion progression. In this paper, it is proposed a review of the current state of the art and future perspectives on the use of cell therapy in obstructive lung diseases.
Similar content being viewed by others
References
GOLD (2011). Global initiative for chronic obstructive lung disease: global strategy for the diagnosismanagement, andprevention of chronic obstructive pulmonary disease (revised, 2011). [cited 2012 Aug 27 2012]; Available from: http://www.goldcopd.org/.
Lucattelli, M., et al. (2010). P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. American Journal of Respiratory Cell and Molecular Biology, 44(3), 423–429.
Mortaz, E., et al. (2010). ATP and the pathogenesis of COPD. European Journal of Pharmacology, 638(1–3), 1–4.
Sueblinvong, V., & Weiss, D. J. (2010). Stem cells and cell therapy approaches in lung biology and diseases. Translational Research, 156(3), 188–205.
Mannino, D. M. (2011). The natural history of chronic obstructive pulmonary disease. Pneumonologia i Alergologia Polska, 79(2), 139–143.
Hackett, T. L., et al. (2010). Oxidative modification of albumin in the parenchymal lung tissue of current smokers with chronic obstructive pulmonary disease. Respiratory Research, 11, 180.
Hind, M., & Maden, M. (2011). Is a regenerative approach viable for the treatment of COPD? British Journal of Pharmacology, 163(1), 106–115.
Rennard, S. I., & Wachenfeldt, K. (2011). Rationale and emerging approaches for targeting lung repair and regeneration in the treatment of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society, 8(4), 368–375.
Mannino, D. M., & Buist, A. S. (2007). Global burden of COPD: risk factors, prevalence, and future trends. Lancet, 370(9589), 765–773.
Ribeiro-Paes, J. T., et al. (2009). Terapia celular em doenças pulmonares: existem perspectivas? Revista Brasileira de Hematologia e Hemoterapia, 31(1), 140–148.
Stolk, J., et al. (2012). Randomised controlled trial for emphysema with a selective agonist of the gamma-type retinoic acid receptor. European Respiratory Journal, 40(2), 306–312.
Lee, J., et al. (2011). Is the aging process accelerated in chronic obstructive pulmonary disease? Current Opinion in Pulmonary Medicine, 17(2), 90–97.
McDonough, J. E., et al. (2011). Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. The New England Journal of Medicine, 365(17), 1567–1575.
WHO (2011). Brazil to become world’s largest smoke-free country. [cited 2012 Aug 27]; Available from: http://www.who.int/fctc/implementation/news/brazil_news/en/.
Jankowich, M. D., & Rounds, S. I. (2012). Combined pulmonary fibrosis and emphysema syndrome: a review. Chest, 141(1), 222–231.
Sueblinvong, V., et al. (2012). Predisposition for disrepair in the aged lung. The American Journal of the Medical Sciences, 344(1), 41–51.
Taylor, J. D. (2010). COPD and the response of the lung to tobacco smoke exposure. Pulmonary Pharmacology & Therapeutics, 23(5), 376–383.
D’Agostino, B., et al. (2010). Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Biological Therapy, 10(5), 681–687.
Huh, J. W., et al. (2011). Bone marrow cells repair cigarette smoke-induced emphysema in rats. American Journal of Physiology. Lung Cellular and Molecular Physiology, 301(3), L255–L266.
Raghavan, N., et al. (2011). Recent advances in pharmacotherapy for dyspnea in COPD. Current Opinion in Pharmacology, 11(3), 204–210.
Rojas, M., et al. (2005). Bone marrow-derived mesenchymal stem cells in repair of the injured lung. American Journal of Respiratory Cell and Molecular Biology, 33(2), 145–152.
Agostini, C. (2010). Stem cell therapy for chronic lung diseases: hope and reality. Respiratory Medicine, 104(Suppl 1), S86–S91.
Moodley, Y., Manuelpillai, U., & Weiss, D. J. (2011). Cellular therapies for lung disease: a distant horizon. Respirology, 16(2), 223–237.
Ribeiro-Paes, J. T., et al. (2011). Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema. International Journal of Chronic Obstructive Pulmonary Disease, 6, 63–71.
Anversa, P., et al. (2012). Regenerative pulmonary medicine: potential and promise, pitfalls and challenges. European Journal of Clinical Investigation, 42(8), 900–913.
Dausset, J. (1954). Presence of A & B antigens in leukocytes disclosed by agglutination tests. Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales, 148(19–20), 1607–1608.
Thomas, E. D., et al. (1957). Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. The New England Journal of Medicine, 257(11), 491–496.
Thomas, E. D., et al. (1959). Supralethal whole body irradiation and isologous marrow transplantation in man. The Journal of Clinical Investigation, 38, 1709–1716.
Blume, K. G., & Thomas, E. D. (2000). A review of autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 6(1), 1–12.
Thomas, E. D. (2000). Landmarks in the development of hematopoietic cell transplantation. World Journal of Surgery, 24(7), 815–818.
Till, J. E., & Mc, C. E. (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research, 14, 213–222.
McCulloch, E. A., & Till, J. E. (2005). Perspectives on the properties of stem cells. Nature Medicine, 11(10), 1026–1028.
Till, J. E., & McCulloch, E. A. (2011). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. 1961. Radiation Research, 175(2), 145–149.
Teo, A. K., & Vallier, L. (2010). Emerging use of stem cells in regenerative medicine. The Biochemical Journal, 428(1), 11–23.
Xu, Y., Shi, Y., & Ding, S. (2008). A chemical approach to stem-cell biology and regenerative medicine. Nature, 453(7193), 338–344.
Watt, F. M., & Driskell, R. R. (2010). The therapeutic potential of stem cells. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 365(1537), 155–163.
Hackett, T. L., Knight, D. A., & Sin, D. D. (2010). Potential role of stem cells in management of COPD. International Journal of Chronic Obstructive Pulmonary Disease, 5, 81–88.
Lee, A. L., et al. (2010). The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial. BMC Pulmonary Medicine, 10, 5.
Ribeiro-Paes, J. T., Stessuk, T., & Kozma, R. d. l. H. (2012). Cell therapy in chronic obstructive pulmonary disease: state of the art and perspectives. In Kian-Chungong (Ed.), Chronic obstructive pulmonary disease—current concepts and practice (pp. 455–474). Rijeka: InTech.
Hegab, A. E., et al. (2010). Isolation and characterization of murine multipotent lung stem cells. Stem Cells and Development, 19(4), 523–536.
Anversa, P., et al. (2011). Tissue-specific adult stem cells in the human lung. Nature Medicine, 17(9), 1038–1039.
Abreu, S. C., et al. (2011). Mechanisms of cellular therapy in respiratory diseases. Intensive Care Medicine, 37(9), 1421–1431.
Kim, C. F., et al. (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 121(6), 823–835.
Fujino, N., et al. (2011). Isolation of alveolar epithelial type II progenitor cells from adult human lungs. Laboratory Investigation, 91(3), 363–378.
Wada, H., et al. (2012). Transplantation of alveolar type II cells stimulates lung regeneration during compensatory lung growth in adult rats. The Journal of Thoracic and Cardiovascular Surgery, 143(3), 711–719 e2.
Chapman, H. A., et al. (2011). Integrin alpha6beta4 identifies an adult distal lung epithelial population with regenerative potential in mice. The Journal of Clinical Investigation, 121(7), 2855–2862.
Pereira, R. F., et al. (1995). Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proceedings of the National Academy of Sciences of the United States of America, 92(11), 4857–4861.
Krause, D. S., et al. (2001). Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell, 105(3), 369–377.
Kotton, D. N., et al. (2001). Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development, 128(24), 5181–5188.
Suratt, B. T., et al. (2003). Human pulmonary chimerism after hematopoietic stem cell transplantation. American Journal of Respiratory and Critical Care Medicine, 168(3), 318–322.
Lama, V. N., et al. (2007). Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. The Journal of Clinical Investigation, 117(4), 989–996.
Adachi, Y., et al. (2006). Treatment and transfer of emphysema by a new bone marrow transplantation method from normal mice to Tsk mice and vice versa. Stem Cells, 24(9), 2071–2077.
Jungebluth, P., et al. (2011). Mesenchymal stem cells restore lung function by recruiting resident and non-resident proteins. Cell Transplantation.
Ohnishi, S., & Nagaya, N. (2008). Tissue regeneration as next-generation therapy for COPD—potential applications. International Journal of Chronic Obstructive Pulmonary Disease, 3(4), 509–514.
Iyer, S. S., Co, C., & Rojas, M. (2009). Mesenchymal stem cells and inflammatory lung diseases. Panminerva Medica, 51(1), 5–16.
Ingenito, E. P., et al. (2012). Autologous lung-derived mesenchymal stem cell transplantation in experimental emphysema. Cell Transplantation, 21(1), 175–189.
Katsha, A. M., et al. (2011). Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Molecular Therapy, 19(1), 196–203.
Prockop, D. J., & Oh, J. Y. (2012). Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Molecular Therapy, 20(1), 14–20.
Arantes, P. M. M. (2007). Emprego de células mononucleares da medula óssea na terapêutica experimental do enfisema. In Interunidades em Biotecnologia. São Paulo: Universidade de São Paulo.
Yao, H., de Boer, W. I., & Rahman, I. (2008). Targeting lung inflammation: novel therapies for the treatment of COPD. Current Respiratory Medicine Reviews, 4(1), 57–68.
Inoue, K., Koike, E., & Takano, H. (2010). Comprehensive analysis of elastase-induced pulmonary emphysema in mice: effects of ambient existing particulate matters. International Immunopharmacology, 10(11), 1380–1389.
Faria, C. A. (2011). Terapêutica experimental com células mononucleares da medula óssea em modelo animal de enfisema pulmonar. In Interunidades em Biotecnologia. São Paulo: Universidade de São Paulo.
Therapeutics, O. (2008). Prochymal. Aug 2012 [cited 2012 Aug 2012]; Available from: http://www.osiris.com/therapeutics.php.
Caramori, G., et al. (2012). Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema. Recenti Progressi in Medicina, 103(1), 31–40.
Tzouvelekis, A., Antoniadis, A., & Bouros, D. (2011). Stem cell therapy in pulmonary fibrosis. Current Opinion in Pulmonary Medicine, 17(5), 368–373.
Acknowledgments
The authors thank Fundunesp – Fundação para o desenvolvimento da UNESP – and the Municipal Government of Assis for the support. The authors Carolina Arruda de Faria, Rodrigo de las Heras Kozma and Talita Stessuk thank were financially supported by Capes – Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Conflict of interest
The authors declare no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
de Faria, C.A., de las Heras Kozma, R., Stessuk, T. et al. Experimental Basis and New Insights for Cell Therapy in Chronic Obstructive Pulmonary Disease. Stem Cell Rev and Rep 8, 1236–1244 (2012). https://doi.org/10.1007/s12015-012-9410-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-012-9410-7